View ALBIREO PHARMA ALBO investment & stock information. Get the latest ALBIREO PHARMA ALBO detailed stock quotes, stock data, Real-Time ECN,

Albireo Pharma's stock was trading at $17.63 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ALBO stock has increased by 86.5% and is now trading at $32.88. View which stocks have been most impacted by COVID-19. What price target have analysts set for ALBO?

Interested in getting the full scoop on ALBO, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place. Albireo Pharma, Inc. (NASDAQ:ALBO) - Wedbush dropped their Q2 2021 earnings estimates for Albireo Pharma in a research report issued to clients and investors on Monday, March 1st. Wedbush analyst L. Moussatos now expects that the biopharmaceutical company will post earnings of ($1.60) per share for the quarter, down from their prior estimate of ($1.59). 2021-02-05 · Analyst recommendations provided by FactSet shows that the consensus forecast for Albireo Pharma Inc. (ALBO) is a “Buy”.

Albireo pharma stock forecast

ALBO stock forecast Our latest prediction for Albireo Pharma Inc's stock price was made on the Jan. 11, 2021 when the stock price was at 37.22$. ALBO stock forecast Our latest prediction for Albireo Pharma Inc's stock price was made on the Jan. 11, 2021 when the stock price was at 37.22$. In the short term (2weeks), ALBO's stock price should underperform the market by -2.81%. During that period the price should oscillate between -10.04% and +8.24%. 2021-04-08 · According to 8 analysts, the average rating for Albireo Pharma stock is "Strong Buy." The 12-month stock price forecast is 73.00, which is an increase of 116.75% from the latest price.

Real-time share price updates and latest news for Albireo Pharma Inc (NASDAQ: ALBO). Compare across sectors, industries & regions.

2021-02-26 · Why Albireo Pharma Stock Is Skyrocketing Today Albireo Pharma, Inc. (ALBO) Q2 2020 Earnings Call Transcript Albireo Pharma, Inc. (ALBO) Q4 2019 Earnings Call Transcript In a report issued on February 9, Berenberg Bank also maintained a Buy rating on the stock with a $214.00 price target. See today’s analyst top recommended stocks >> Albireo Pharma (ALBO) In a report released today, Joseph Stringer from Needham assigned a Buy rating to Albireo Pharma, with a price target of $68.00. 2020-09-11 · Albireo Pharma, Inc. (NASDAQ:ALBO) showed a performance of 49.98% in past 30-days.

Albireo Pharma Inc Stock Forecast. Over the next 52 weeks, Albireo Pharma Inc has on average historically risen by 1.8 % based on the past 13 years of stock performance.; Albireo Pharma Inc has risen higher in 5 of those 13 years over the subsequent 52 week period, corresponding to a historical accuracy of 38.46 %

The average price target represents a 94.81% upside from the last price of $36.74. View ALBIREO PHARMA ALBO investment & stock information. Get the latest ALBIREO PHARMA ALBO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Albireo Pharma, Inc. (NASDAQ:ALBO) – Analysts at Piper Sandler issued their Q3 2022 EPS estimates for Albireo Pharma in a report released on Sunday, February 28th. Piper Sandler analyst Y. Rahimi Name Hold Shares Value Type; Solomon Steiner: 79.14%: 15,097,733: $542.91M: Insider: Ventures Llc Steiner: 21.20%: 4,044,266: $145.43M: Insider: Samuel P. Wertheimer

If you had invested in Albireo Pharma stock at $2,160.00, your return over the last 13 years would have been -98.37%, for an annualized return of -27.14%. Albireo Pharma Forecast Models Albireo Pharma time-series forecasting models is one of many Albireo Pharma's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data.
Fackombud

Most Recent Rating. Jefferies Financial Group is very positive to ALBO and gave it a "Positive - Buy" rating on March 26, 2021.

Albireo Pharma Inc Stock Price Forecast, "ALBO" Predictons for2021 About the Albireo Pharma, Inc. stock forecast Unlock SECRET Features HERE for $1!
Svensk finsk oversattning

antalet muslimer i varlden
sangar sundsvall
poliser det är tid att välja sida
marlene en tienie
scb statistikdatabasen api
ack värmland vilka dagar
dag hammarskjold stamp value

including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to ALBO (Albireo Pharma) stock.

Albireo Pharma's market cap is $628.5 million. Measures a public company's total equity value as implied by the stock's last observed trading price.

Top safe safir 10
niklas karlsson jönköping

22 Dec 2020 57.21% of the stock of Albireo Pharma is held by institutions. The stock options are exercisable at a price of $39.77 per share, the closing …

Time-series forecasting models ae widely used for non-stationary data. Why Albireo Pharma Stock Is Skyrocketing Today Thursday, 27 August 2020 yahoo. How Much Of Albireo Pharma, Inc. Do Institutions Own? Friday, 21 August 2020 The average price target is $68.29, with a high forecast of $81.00 and a low forecast of $52.00.

2021-03-04

Find out more. According to the market data, Albireo Pharma Inc (ALBO) stock price is $35.96 and the 52 weeks low is $14.37, which means the Albireo Pharma Inc stock price is up 130.22% in the last 12 months. Albireo Pharma Inc (ALBO) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some ALBO stock forecast Our latest prediction for Albireo Pharma Inc's stock price was made on the Jan. 11, 2021 when the stock price was at 37.22$.. In the short term (2weeks), ALBO's stock price should underperform the market by -2.81%.During that period the price should oscillate between -10.04% and +8.24%..

8 analysts offering their recommendations for the stock have an average rating of 1.50, where 0 rate it as a Hold and 1 think it is a “Overweight”. 7 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform. 2021-03-20 · Albireo Pharma, Inc. (ALBO) registered a 3.87% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 6.25% in intraday trading to $38.38 this Tuesday, Mar 16, hitting a weekly high. The stock’s 5-day price performance is -3.64%, and it has moved by -5.12% in 30 days. In a report issued on March 26, Jefferies also reiterated a Buy rating on the stock with a $310.00 price target.